Symphony Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
+5,763
| New | +$222K | 0.03% | 238 |
|
|
2025
Q1 | – | Sell |
-8,397
| Closed | -$284K | – | 149 |
|
|
2024
Q4 | $284K | Buy |
8,397
+209
| +3% | +$7.06K | 0.04% | 183 |
|
|
2024
Q3 | $333K | Sell |
8,188
-96
| -1% | -$3.91K | 0.06% | 177 |
|
|
2024
Q2 | $320K | Buy |
8,284
+382
| +5% | +$14.8K | 0.06% | 162 |
|
|
2024
Q1 | $339K | Hold |
7,902
| – | – | 0.08% | 142 |
|
|
2023
Q4 | $315K | Buy |
+7,902
| New | +$315K | 0.07% | 163 |
|
|
2023
Q3 | – | Sell |
-7,440
| Closed | -$264K | – | 173 |
|
|
2023
Q2 | $264K | Sell |
7,440
-15,005
| -67% | -$531K | 0.06% | 163 |
|
|
2023
Q1 | $792K | Buy |
22,445
+3,622
| +19% | +$128K | 0.21% | 98 |
|
|
2022
Q4 | $659K | Buy |
+18,823
| New | +$659K | 0.17% | 108 |
|